ReviewFrontiers in oncology2023

Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases.

Enrico La Spina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.